• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [22099 Records] Selected Records [0 Hits] [Clear]
Year Source Title
1998     Wessex Institute for Health Research and Development (WIHRD) Tinnitus retraining therapy
2001     Wessex Institute for Health Research and Development (WIHRD) Pre- and peri-operative antibiotic prophylaxis for colorectal surgery
1998     Wessex Institute for Health Research and Development (WIHRD) The use of olanzapine as a first and second choice treatment in schizophrenia
2001     Wessex Institute for Health Research and Development (WIHRD) Pre-implantation diagnosis
2001     Wessex Institute for Health Research and Development (WIHRD) Functional electrical stimulation for limb motor dysfunction following stroke
2001     Wessex Institute for Health Research and Development (WIHRD) Brachytherapy for localised prostate cancer
2001     Wessex Institute for Health Research and Development (WIHRD) Surgical interventions for morbid obesity
2001     Wessex Institute for Health Research and Development (WIHRD) Effects of TNF-alpha antagonists in people with rheumatoid arthritis
2001     Wessex Institute for Health Research and Development (WIHRD) Ambulatory versus conventional blood pressure monitoring
2002     Wessex Institute for Health Research and Development (WIHRD) Growth hormone replacement therapy for adults with growth hormone deficiency
2002     Wessex Institute for Health Research and Development (WIHRD) Immunotherapy for seasonal rhinitis, asthma and bee sting venom allergy
2002     Wessex Institute for Health Research and Development (WIHRD) Cox-II inhibitors versus non-steroidal anti-inflammatory drugs in rheumatoid and osteoarthritis patients: gastrointestinal effects
2002     Wessex Institute for Health Research and Development (WIHRD) Acetylcholinesterase inhibitors: donepezil, rivastigmine, tacrine or galantamine for non-Alzheimer's dementia
2002     Wessex Institute for Health Research and Development (WIHRD) Pre-operative delay after femoral fracture
2002     Wessex Institute for Health Research and Development (WIHRD) Insulin pumps, conventional and intensive multiple injection insulin therapy for type 1 diabetes mellitus
2002     Wessex Institute for Health Research and Development (WIHRD) Outpatient physiotherapy services for low back pain
2002     Wessex Institute for Health Research and Development (WIHRD) Update report: Non-myeloablative bone marrow and peripheral blood stem cell transplant
2002     Wessex Institute for Health Research and Development (WIHRD) Hyperbaric oxygen therapy for multiple sclerosis
2002     Wessex Institute for Health Research and Development (WIHRD) Lung volume reduction surgery for diffuse emphysema
2002     Wessex Institute for Health Research and Development (WIHRD) Selective denervation for spasmodic torticollis
2002     Wessex Institute for Health Research and Development (WIHRD) Imatinib for gastrointestinal stromal tumours
2002     Wessex Institute for Health Research and Development (WIHRD) Hyperbaric oxygen therapy for carbon monoxide poisoning
2002     Wessex Institute for Health Research and Development (WIHRD) Hyperbaric oxygen therapy in people with necrotising fasciitis or Fournier's gangrene
2002     Wessex Institute for Health Research and Development (WIHRD) Hyperbaric oxygen therapy for central retinal artery occlusion
2002     Wessex Institute for Health Research and Development (WIHRD) Hyperbaric oxygen therapy for central osteoradionecrosis
2002     Wessex Institute for Health Research and Development (WIHRD) Immediate versus delayed breast reconstruction
1999     Wessex Institute for Health Research and Development (WIHRD) Reducing the interval for diabetic retinal screening
2003     Wessex Institute for Health Research and Development (WIHRD) Cosmetic breast augmentation
2000     Wessex Institute for Health Research and Development (WIHRD) Dalteparin and enoxaparin for unstable angina and non-Q-wave myocardial infarction: update
2003     Wessex Institute for Health Research and Development (WIHRD) Outcomes of abdominoplasty
2003     Wessex Institute for Health Research and Development (WIHRD) Arthroscopic lavage for knee osteoarthritis
2003     Wessex Institute for Health Research and Development (WIHRD) Sympathectomy for facial blushing
2003     Wessex Institute for Health Research and Development (WIHRD) Coil embolisation of ruptured or unruptured intracranial aneurysms
2003     Wessex Institute for Health Research and Development (WIHRD) Cardiac resynchronisation for heart failure
2003     Wessex Institute for Health Research and Development (WIHRD) Successive attempts at in vitro fertilization
2003     Wessex Institute for Health Research and Development (WIHRD) Update report: Effects of desensitisation treatments and clinical ecology for multiple chemical sensitivity and related disorders
2003     Wessex Institute for Health Research and Development (WIHRD) Uterine artery embolisation for fibroids
2003     Wessex Institute for Health Research and Development (WIHRD) Cochlear implants in adults
2003     Wessex Institute for Health Research and Development (WIHRD) Bernese periacetabular osteotomy for developmental dysplasia of the hip
2003     Wessex Institute for Health Research and Development (WIHRD) Hypnotherapy for anxiety disorders
2003     Wessex Institute for Health Research and Development (WIHRD) Laser treatment of unwanted hair
2003     Wessex Institute for Health Research and Development (WIHRD) Alemtuzumab for chronic lymphocytic leukaemias
2003     Wessex Institute for Health Research and Development (WIHRD) Oesophago-oesophageal anastomosis for oesophageal atresia or stenosis in children
2003     Wessex Institute for Health Research and Development (WIHRD) Oesophago-gastric anastomosis and interposition surgery for oesophageal atresia or stenosis in children
2003     Wessex Institute for Health Research and Development (WIHRD) Music therapy for children with autistic spectrum disorder
2003     Wessex Institute for Health Research and Development (WIHRD) Spinal manipulation for chronic low back pain
1999     Wessex Institute for Health Research and Development (WIHRD) The use of interferon alfa in the treatment of metastatic cutaneous melanoma
1999     Wessex Institute for Health Research and Development (WIHRD) Combination therapy (ribavirin and interferon alfa) to replace interferon alfa alone for the treatment of patients with moderate hepatitis C
1998     Wessex Institute for Health Research and Development (WIHRD) Irinotecan as second line chemotherapy in colorectal cancer (preliminary report)
1998     Wessex Institute for Health Research and Development (WIHRD) Psycho-social interventions in oncology: counselling services for women with breast cancer
1998     Wessex Institute for Health Research and Development (WIHRD) Stents for coronary artery disease (CAD)
1998     Wessex Institute for Health Research and Development (WIHRD) Surgical gender reassignment for male to female transsexual people
2003     Wessex Institute for Health Research and Development (WIHRD) Sensory or auditory integration therapy for children with autistic spectrum disorders
2003     Wessex Institute for Health Research and Development (WIHRD) Hyperbaric oxygen for osteomyelitis
2003     Wessex Institute for Health Research and Development (WIHRD) Enzyme replacement therapy for Fabry's disease
2004     Wessex Institute for Health Research and Development (WIHRD) Music therapy for children with autistic spectrum disorder
2004     Wessex Institute for Health Research and Development (WIHRD) Artificial anal sphincter for faecal incontinence
2004     Wessex Institute for Health Research and Development (WIHRD) Spinal manipulation for chronic neck pain
1999     Wessex Institute for Health Research and Development (WIHRD) Beta intererons (1a and 1b) in elapsing-remitting and secondary progressive multiple sclerosis
1999     Wessex Institute for Health Research and Development (WIHRD) Orlistat for the treatment of obesity
1999     Wessex Institute for Health Research and Development (WIHRD) Surveillance of Barrett's oesophagus
1999     Wessex Institute for Health Research and Development (WIHRD) Left ventricular assist devices (LVADs) for end stage heart failure
2001     Wessex Institute for Health Research and Development (WIHRD) Deep brain stimulation for movement disorders other than Parkinsons disease
1999     Wessex Institute for Health Research and Development (WIHRD) Entacapone as an adjunctive treatment to levodopa in Parkinson's disease
1999     Wessex Institute for Health Research and Development (WIHRD) Pallidotomy, thalamotomy and deep brain stimulation for severe Parkinson's disease
1999     Wessex Institute for Health Research and Development (WIHRD) Leflunomide: a new disease modifying drug for rheumatoid arthritis
1998     Wessex Institute for Health Research and Development (WIHRD) Rivastigmine (Exelon TM) in the treatment of senile dementia of the Alzheimer type (SDAT)
1998     Wessex Institute for Health Research and Development (WIHRD) Therapeutic ultrasound in physiotherapy
1998     Wessex Institute for Health Research and Development (WIHRD) Eye movement desensitization and reprocessing in the treatment of post traumatic stress disorder
1998     Wessex Institute for Health Research and Development (WIHRD) Exercise testing following unstable coronary artery disease or myocardial infarction
2004     Wessex Institute for Health Research and Development (WIHRD) Cognitive behavioural therapy in children with autistic spectrum disorder
2004     Wessex Institute for Health Research and Development (WIHRD) Free-standing midwife-led maternity units
1999     Wessex Institute for Health Research and Development (WIHRD) Low molecular weight heparins (dalteparin and enoxaparin) compared with unfractionated heparin for unstable angina and non-Q-wave myocardial infarction
1999     Wessex Institute for Health Research and Development (WIHRD) Hospital-based pulmonary rehabilitation programmes for patients with severe chronic obstructive pulmonary disease
1999     Wessex Institute for Health Research and Development (WIHRD) DNase for cystic fibrosis patients with mild to moderate lung disease
1999     Wessex Institute for Health Research and Development (WIHRD) Glyceryl trinitrate for chronic anal fissures
1999     Wessex Institute for Health Research and Development (WIHRD) Irinotecan as second line chemotherapy in colorectal cancer
1998     West Midlands Health Technology Assessment Collaboration (WMHTAC) Laser resurfacing of the skin for the improvement of facial acne scarring
1998     West Midlands Health Technology Assessment Collaboration (WMHTAC) Sildenafil: an oral drug for the treatment of male erectile dysfunction
2005     West Midlands Health Technology Assessment Collaboration (WMHTAC) The effectiveness and cost effectiveness of immunoglobulin replacement therapy for primary immunodeficiency and chronic lymphocytic leukaemia: a systematic review and economic evaluation
2005     West Midlands Health Technology Assessment Collaboration (WMHTAC) Probiotics for the prevention of antibiotics associated diarrhea: a systematic review
1999     West Midlands Health Technology Assessment Collaboration (WMHTAC) The effectiveness of the mirena coil (levonorgestrel-releasing intrauterine system) in menorrhagia
1999     West Midlands Health Technology Assessment Collaboration (WMHTAC) In-patient versus out-patient care for eating disorders
2000     West Midlands Health Technology Assessment Collaboration (WMHTAC) Electrodiagnostic techniques in the pre-surgical assessment of patients with carpal tunnel syndrome
2001     West Midlands Health Technology Assessment Collaboration (WMHTAC) A systematic review of the effectiveness and cost-effectiveness of palivizumab (Synagis(R)) in the prevention of respiratory syncytial virus (RSV) infection in infants at high risk of infection
2002     West Midlands Health Technology Assessment Collaboration (WMHTAC) The effectiveness and cost-effectiveness of somatostatin analogues in the treatment of acromegaly
2000     West Midlands Health Technology Assessment Collaboration (WMHTAC) The effectiveness of toluidine blue dye as an adjunct to oral cancer screening in general dental practice
2002     West Midlands Health Technology Assessment Collaboration (WMHTAC) The effectiveness of health assessments in primary care as a strategy for improving both physical and mental health in patients with schizophrenic illness
2007     West Midlands Health Technology Assessment Collaboration (WMHTAC) A systematic review of the clinical and cost-effectiveness of psychological therapy involving family and friends in alcohol misuse or dependence
2005     West Midlands Health Technology Assessment Collaboration (WMHTAC) The clinical and cost effectiveness of biventricular pacing for patients with severe heart failure: addendum report ; January 2005 [updated January 2006]
1999     West Midlands Health Technology Assessment Collaboration (WMHTAC) Percutaneous endoscopic gastrostomy (PEG) feeding in the enteral nutrition of dysphagic stroke patients
2002     West Midlands Health Technology Assessment Collaboration (WMHTAC) Outpatient diagnosis of endometrial cancer in women with first episode of postmenopausal bleeding
1999     West Midlands Health Technology Assessment Collaboration (WMHTAC) Parent education programmes for children's behaviour problems. Medium to long term effectiveness
2007     West Midlands Health Technology Assessment Collaboration (WMHTAC) The clinical effectiveness and cost-effectiveness of pegvisomant for the treatment of acromegaly: a systematic review
2004     West Midlands Health Technology Assessment Collaboration (WMHTAC) Provocation-neutralisation testing and therapy for food allergy
2007     West Midlands Health Technology Assessment Collaboration (WMHTAC) The clinical and cost-effectiveness of immunoprophylaxis against respiratory syncytial virus with palivizumab in children
2008     West Midlands Health Technology Assessment Collaboration (WMHTAC) The effectiveness and cost-effectiveness of coloured filters for reading disability: a systematic review
2008     West Midlands Health Technology Assessment Collaboration (WMHTAC) The clinical and cost-effectiveness of intensive versus standard lipid lowering with statins in the prevention of cardiovascular events amongst patients with acute coronary syndromes: a systematic review
2008     West Midlands Health Technology Assessment Collaboration (WMHTAC) Prevalence and prognosis of paroxysmal nocturnal haemoglobinurea and the clinical and cost-effectiveness of eculizumab
2000     West Midlands Health Technology Assessment Collaboration (WMHTAC) Hyperbaric oxygen therapy in the management of carbon monoxide poisoning, osteoradionecrosis, burns, skin grafts and crush injury